To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A New York developer purchased ...
One way of viewing efforts by storage suppliers to move into data management over the past couple of years is that storage technology is emerging from the backroom and wants to be at the centre of ...
Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...
In his 1960 book Theory and Design in the First Machine Age, the critic and historian Reyner Banham presciently noted a growing chasm between technological change and the capacity of designers to ...
Immunogenicity refers to a biopharmaceutical’s ability to generate an immune response upon administration. It is a major concern in biologics development because it can cause adverse events in ...
Structure Therapeutics' stock has declined over 40% since last year, but its differentiated technology platform and promising drug pipeline still support a "Buy" rating. Structure's lead candidate, ...
A young computer scientist and two colleagues show that searches within data structures called hash tables can be much faster than previously deemed possible. Sometime in the fall of 2021, Andrew ...
With MassiveFold, scientists have unlocked AlphaFold's full potential, making high-confidence protein predictions faster and more accessible, fueling breakthroughs in biology and drug discovery. Brief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results